SEC 13F Intelligence

Managers / Q4 2021 · view latest →

Roumell Asset Management, LLC

CIK 0001331693 · 2 WISCONSIN CIR, SUITE 700, CHEVY CHASE, MD, 20815 · 301-656-8500

Reported Value
$75M
Q4 2021
Positions
21
Filings on Record
23
2019–present window
Filed
Feb 11, 2022
original filing

Summary

Roumell Asset Management, LLC reported $75M in U.S.-listed holdings across 21 positions for Q4 2021.

Its largest position, GSIT, represents 12.1% of the portfolio.

Compared with Q3 2021, the fund opened 6 new positions and exited 2.

Portfolio Metrics

Turnover
+20.6%
vs prior filed quarter
Top-10 Concentration
+79.5%
share of reported value
Largest Position
+12.1%
Gsi Technology
New / Exited
6 / 2
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $48MQ4 ’18Q1 ’19: $41MQ2 ’19: $42MQ3 ’19: $42MQ3 ’19Q4 ’19: $44MQ1 ’20: $37MQ2 ’20: $41MQ2 ’20Q3 ’20: $50MQ4 ’20: $64MQ1 ’21: $69MQ1 ’21Q2 ’21: $86MQ3 ’21: $75MQ4 ’21: $75MQ4 ’21Q1 ’22: $62MQ2 ’22: $51MQ3 ’22: $46MQ3 ’22Q4 ’22: $40MQ1 ’23: $44MQ2 ’23: $51MQ2 ’23Q3 ’23: $50MQ4 ’23: $47MQ1 ’24: $53MQ1 ’24Q2 ’24: $53Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 69.4%Other: 21.4%ADR: 9.3%
  • Common Stock · 69.4% · $52M
  • Other · 21.4% · $16M
  • ADR · 9.3% · $7M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MGNIMAGNITE INCNEW+240.0K240.0K+$4M$4M
CMTLCOMTECH TELECOMMUNICATIONS CNEW+101.6K101.6K+$2M$2M
AMYRIS INCNEW+430.0K430.0K+$2M$2M
TTITETRA TECHNOLOGIES INC DELNEW+704.3K704.3K+$2M$2M
ETONETON PHARMACEUTICALS INCNEW+449.4K449.4K+$2M$2M
KVHIKVH INDS INCNEW+76.3K76.3K+$701,000$701,000
EROS STX GLOBAL CORPORATIONSOLD OUT1.15M0$1M$0
CLMBWAYSIDE TECHNOLOGY GROUP INCSOLD OUT16.8K0$453,000$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2021

21 positions
#IssuerClass% PortfolioValueShares
1GSITGSI TECHNOLOGY INChistory →COM12.07%$9M1.96M
2QUANTUM CORPCOM NEW11.51%$9M1.56M
3COLLPLANT BIOTECHNOLOGIES LTSHS NEW10.81%$8M495.7K
4ENZBENZO BIOCHEM INChistory →COM10.43%$8M2.44M
5ALLOT LTDSHS9.72%$7M614.0K
6OPRAOPERA LTDhistory →SPONSORED ADS7.48%$6M794.4K
7MGNIMAGNITE INChistory →COM5.60%$4M240.0K
8COMSCORE INCCOM5.55%$4M1.25M
9CMTLCOMTECH TELECOMMUNICATIONS Chistory →COM NEW3.21%$2M101.6K
10QUMU CORPCOM3.10%$2M1.10M
11AMYRIS INCCOM NEW3.10%$2M430.0K
12TTITETRA TECHNOLOGIES INC DELhistory →COM2.67%$2M704.3K
13ETONETON PHARMACEUTICALS INChistory →COM2.57%$2M449.4K
14BCDABIOCARDIA INChistory →COM2.43%$2M938.4K
15EHTHEHEALTH INChistory →COM2.08%$2M61.2K
16NODKNI HLDGS INChistory →COM2.07%$2M82.1K
17SPARK NETWORKS SESPONSORED ADR1.79%$1M426.4K
18ARDSARIDIS PHARMACEUTICALS INChistory →COM1.39%$1M446.6K
19KVHIKVH INDS INCCOM0.93%$701,00076.3K
20STREAMLINE HEALTH SOLUTIONSCOM0.83%$625,000425.0K
21RICEBRAN TECHNOLOGIESCOM NEW0.66%$493,0001.41M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$53M16Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$53M17May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$47M15Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$50M19Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$51M22Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$44M20May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$40M21Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$46M21Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$51M21Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$62M19May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$75M21Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$75M17Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$86M18Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$69M14May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$64M16Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$50M14Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$41M20Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$37M22May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$44M21Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$42M14Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$42M18Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$41M20May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$48M22Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.